small smart solutions
Meet us at the 2nd MPS World Summit, Berlin, Germany.
We are eagerly awaiting the second installation of this spearheading conference and summit about emulating human biology for patients’ benefits, reducing animal testing and faster and saver drug development.
Our unique Biosensors for continuously measuring Glucose, Lactate, Glutamine and Glutamate in Organ on a Chip and other microphysiological systems will enable deeper insights into these organisms and allow sophisticated algorithmics and AI to generate better models and predictions of MPS.
We will join the second summit of the 2022 founded International MPS Society (IMPSS) and present our offerings, products, and technology to the attending visitors.
MPS World Summit, Berlin, Germany, 26. June — 30. June 2023
Zur Verstärkung unseres Teams suchen wir eine/n technisch orientierte/n Mitarbeiterin/Mitarbeiter.
Klicken Sie hier für die detaillierte Ausschreibung. Wir freuen uns auf Ihre Bewerbung!
Meet us at React4life, BIC-FILSE, Genoa, Italy.
Jobst Technologies is among the few companies exhibiting at the first Organ on a Chip MaterClass 2023.
We will bring our unique flow through cells for continuously measuring Glucose, Lactate, Glutamine and Glutamate in perfusion streams of OoaC Systems.
Looking forward to engage with our fellow exhibitors as well as all the participants.
Organ on a chip MasterClass, Geneva, Italy, 24. January — 25. January 2023
CELLEC BIOTEK AG develops and commercializes perfusion-based bioreactor systems for 3D cell culture. The resulting tissues are used as advanced models of development, physiology, pathology, and drug testing, and prospectively as engineered grafts for tissue and organ regeneration.
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical industry. Founded in 2009, InSphero’s patent-pending technologies and methods enable large-scale, reproducible production of scaffold-free 3D microtissues for application in the field of liver safety, metabolic disease, and immune oncology. In recent years, innovative organ-on-chip concepts for automation-compatible multi-organ experiments have been presented, elevating in vitro testing to a next level of physiological relevance.
Jobst Technologies is the global competence and performance leader for biosensor monitoring applications. The microfluidic operation of the multi-parametric sensor systems allows for real-time monitoring and control of metabolic parameters (Lactate, Glucose, Glutamine) critical for organ on a chip systems.
Microfluidic ChipShop is one of the leading microfluidic products and service providers. A unique feature of the company is its catalogue with a huge variety of off-the-shelf microfluidic components and systems, allowing a low-cost rapid access to lab-on-a-chip technologies, such as Organ-on-Chip.
React4life is an Italian biotech company which patented MIVO® (Multi In Vitro Organ).
This cutting-edge microphysiological system enables researchers to overcome the limits of current in vitro assays and animal models. It improves the reliability and predictivity of several applications: pharmaceutical drug-testing, personalized medicine, novel immuno-oncology therapies, cosmetics, dermatology, and nutraceutical.
Meet us at the Advanced Therapies Europe, September 6th — September 7th, 2023.
Jobst Technologies will be part of the Advanced Therapies Europe Event. The meeting provides a platform to strengthen the european capabilities in cell and gene manufacturing and therapy development through building networks within Europe as well as world wide between global Leaders in the industry.
Together with the other attending Technology and Therapy Leaders we will present our biosensors as solutions for Glucose, Lactate, Glutamine and Glutamate monitoring in Cell and Gene Therapy R&D and production.
Visit our booth to connect and exchange about making critical metabolic parameters available for advanced data processing and automation.
Advanced Therapies Europe, Lisboa, Portugal, 06. September — 07. September 2023
Biosensor Support Grant for CGT projects by Jobst Technologies GmbH
In Cell and Gene Therapy (CGT) development and manufacturing excessive needs are placed on repeatability, safety and quality, as well as on process stability. During production crucial insights into the cells condition are gained by monitoring metabolic parameters including Glucose, Lactate and others. Monitoring such parameters is typically done by analyzing samples in large, expensive and complex analyzing instruments that are not available to every researcher and smaller scale company.
Unlike many other bio-pharma therapy products, CGT is depending on reliable processing of small, often patient-derived sample volumes, for which closed-loop metabolic monitoring and control contribute to process success and scalability. The biosensors by Jobst Technologies offer robust and high performing enzymatic based sensor components that enable continuous monitoring as well as automated measurement of small sample volumes. To support the CGT community and advance innovation, we are providing selected projects with our products and expertise to achieve such functionality.
The projects selected for a Biosensor Support Grant for CGT will receive the needed amount of B.LV5 continuous electrochemical biosensors for the measurement of Glucose, Lactate, Glutamine and Glutamate in a flow-through sensor package. This also includes our SIX Read-Out transmitter as well as a ready-to-use software and an open communication protocol. During the project we will be available to assist with sensor integration, give application support, and can further support your automation system with our CPP1 micropumps including the utilization of pre-sterilized microdialysis probes.
We are looking forward to get in contact with you and to review your proposals!
If you are interested, please visit the detailed information at https://www.jobst-technologies.com/biosensor-cgt-support-grant/
Meet us at the Advanced Therapies Europe, August 31st — September 1st, 2022.
Jobst Technologies will be part of the Advanced Therapies Europe Event. The meeting provides a platform to strengthen the european capabilities in cell and gene manufacturing and therapy development through building networks within the UK and Europe as well as to global Leaders in the industry.
Together with the other attending Technology and Therapy Leaders we will present our biosensors as solutions for Glucose, Lactate, Glutamine and Glutamate monitoring in Cell and Gene Therapy R&D and production.
Visit our booth to connect and exchange about making critical metabolic parameters available for advanced data processing and automation.
Advanced Therapies Europe, London, 31. August — 01. September 2022